CClinicalTrials.gg
CompletedNCT02627534Updated Dec 14, 2015

Effects of Adjunct Photodynamic Therapy in the Treatment of Type 2 Diabetic Patients With Chronic Periodontitis

An interventional study of Ultrasonic debridement and Antimicrobial photodynamic therapy in Chronic Periodontitis and Diabetes Mellitus, sponsored by Universidade Estadual Paulista Júlio de Mesquita Filho. Completed at 1 site in Brazil. Open to participants aged 35 Years and older. Per ClinicalTrials.gov, last updated 2015-12-14.

Sponsored by Universidade Estadual Paulista Júlio de Mesquita Filho · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
35 Years and older
Sex
All
01

Study summary

Periodontal Diseases are considered the sixth complication of Diabetes Mellitus (DM). This close relationship between both diseases is characterized by mutual influence. The presence of DM might impair prognosis of diverse dental treatments due to its inflammatory nature, negative influence on wound healing, on bone biology, and the establishment of infections. Consequently, knowledge of new dental therapies and the biology of dental treatments for chronic periodontitis in diabetic patients can enhance quality of life and make these treatments more adequate for this common profile of patients.

Read the detailed description

Diabetes mellitus (DM) has become a global epidemic. Its complications can have a significant impact on quality of life, longevity, and costs in public health. The World Health Organization (WHO) estimates that by 2030, 439 million people will suffer from diabetes, around 10% of the world adult population (WHO, 2011). Periodontal Diseases are considered the sixth complication of DM. This close relationship between both diseases is characterized by mutual influence. Thus, an appropriate control of periodontal disease may facilitate the DM control, improving quality of life on diabetes patients. Besides that, the presence of DM might impair prognosis of diverse dental treatments due to its inflammatory nature, negative influence on wound healing, on bone biology, and the establishment of infections. Consequently, knowledge of new dental therapies and the biology of dental treatments for chronic periodontitis in diabetic patients can enhance quality of life and make these treatments more adequate for this common profile of patients. Therefore, the aim of the present study is to investigate the effectiveness of antimicrobial photodynamic therapy as adjunct to full-mouth debridement for the treatment of periodontitis in type 2 diabetic patients through a split-mouth randomized triple-blind clinical trial.

02

Conditions studied

  • Chronic Periodontitis
  • Diabetes Mellitus

Keywords

  • Photodynamic therapy
  • Ultrasonic debridement
  • Chronic periodontitis
  • Type 2 diabetes
03

In context

Periodontitis

1,635 studies on the registry are indexed under Periodontitis; 327 are open to participants now.

This study's enrollment of 20 is below the median of 45 across 1,191 interventional studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

Universidade Estadual Paulista Júlio de Mesquita Filho is the lead sponsor of 82 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • diagnosis of type 2 DM for ≥5 years
  • DM treatment with oral hypoglycemic agents or insulin supplementation and diet
  • glycated hemoglobin (HbA1c) levels from 6.5% to 11%
  • at least 15 teeth (excluding third molars and teeth indicated for extraction)
  • moderate to severe generalized chronic periodontitis (Armitage, 1999)
  • agree and sign the formal consent to participate in the study after receiving an explanation of risks and benefits from an individual who was not a member of the study (Resolution number 196 - October, 1996, and Ethics and Code of Professional Conduct in Dentistry - CFO179/93).

Exclusion criteria

Exclusion Criteria:

  • medical conditions that required prophylactic antimicrobial coverage
  • SRP in the previous 6 months
  • antimicrobial therapies in the previous 6 months
  • anti-inflammatory therapies in the previous 6 months
  • systemic conditions, other than DM, that could affect the progression of chronic periodontitis
  • current use of medication that could interfere with periodontal response to treatment
  • pregnancy or lactation
  • smoking
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
20 participants (actual)

Study arms

  • Active comparator
    Ultrasonic Debridement (UD)

    Ultrasonic Debridement (UD) (n=20)

    Procedure: Ultrasonic debridement

  • Experimental
    UD + Antimicrobial Photodynamic Therapy

    Ultrasonic Debridement + aPDT (UD+aPDT) (n=20)

    Procedure: Ultrasonic debridement · Procedure: Antimicrobial photodynamic therapy

Interventions

  • ProcedureUltrasonic debridement

    All periodontal pockets received ultrasonic debridement (Cavitron, Dentsply) with specific inserts (UI25KSF10S, Hu-Friedy). All diseased sites were instrumented in one session by an experienced periodontist.

  • ProcedureAntimicrobial photodynamic therapy

    After ultrasonic debridement, one randomly selected periodontal pocket received an additional aPDT performed by a trained operator (NMRBA). One pocket with probing depth ≥ 5mm in each patient was randomly selected to aPDT. After washing the pocket with saline solution, the photosensitizer (methylene blue 10mg/ml) was applied to the bottom of the pocket in a coronal direction. Following this, the pocket was exposed to a diode laser light with a fibre optic application for 1 min (Thera Lase DMC - Brazil), with wavelength of 660nm, power of 60mW and fluency of 129J/cm2.

06

What researchers measure

Primary outcomes

  1. Probing Depth

    Assessed with manual probe (North Carolina, Hu-Friedy)

    Time frame: Reductions in Probing Depth was compared at baseline and 180 days

Secondary outcomes

  1. Clinical Attachment Level

    Assessed with manual probe (North Carolina, Hu-Friedy)

    Time frame: Clinical Attachment Level gain was compared at baseline and 180 days

Other outcomes

  1. Gingival Recession

    Assessed with manual probe (North Carolina, Hu-Friedy)

    Time frame: Gingival Recession changes was compared at baseline and 180 days

07

Study locations

1 site
  • Instituto de Ciência e Tecnologia de São José dos Campos - UNESP
    Sâo José dos Campos, São Paulo 12245-000, Brazil
08

References and documents

Publications

  • Castro Dos Santos NC, Andere NM, Araujo CF, de Marco AC, Dos Santos LM, Jardini MA, Santamaria MP. Local adjunct effect of antimicrobial photodynamic therapy for the treatment of chronic periodontitis in type 2 diabetics: split-mouth double-blind randomized controlled clinical trial. Lasers Med Sci. 2016 Nov;31(8):1633-1640. doi: 10.1007/s10103-016-2030-8. Epub 2016 Jul 22. PubMed 27448223 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 14, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02627534
Lead sponsor
Universidade Estadual Paulista Júlio de Mesquita Filho
Responsible party
Nídia Cristina Castro dos Santos (DDS, Universidade Estadual Paulista Júlio de Mesquita Filho) — Principal investigator
First posted
Dec 11, 2015
Start date
Apr 2014
Primary completion
Mar 2015
Completion
Oct 2015
Last update
Dec 14, 2015

Study contacts

Mauro P Santamaria, PhD
study director · ICT - UNESP

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion